Key result
Metformin attenuates hyperglycemia-induced vascular fibrosis markers by inhibiting TGF-β1/SMAD2/3 signaling.
Why the study?
Molecular mechanisms underlying the diverse therapeutic effects of metformin beyond anti-hyperglycaemic actions remain unclear, specifically whether it inhibits pro-fibrotic gene expression by targeting DDR2 in adventitial fibroblasts.
Does metformin reduce pro-fibrotic gene expression in vascular adventitial fibroblasts exposed to hyperglycemic conditions?
Does metformin reduce pro-fibrotic gene expression in vascular adventitial fibroblasts exposed to hyperglycemic conditions?
p-value: p=≤0.05
Metformin exerts anti-fibrotic effects in vascular cells under hyperglycemic conditions by downregulating DDR2 via the TGF-β1 pathway, suggesting a molecular basis for its cardiovascular protective benefits in diabetes.
Hypothesis-generating for metformin's anti-fibrotic effects in diabetic vessels; extends preclinical mechanisms but leaves open human translation.
Molecular mechanisms underlying the diverse therapeutic effects of anti-diabetic metformin, beyond its anti-hyperglycaemic effects, remain largely unclear. Metformin is reported to reduce the long-term complications of diabetes, including cardiovascular fibrosis and remodelling. Our recent investigations show that Discoidin Domain Receptor 2 (DDR2), a Collagen receptor tyrosine kinase, has an obligate regulatory role in Collagen type I gene expression in cardiac and vascular adventitial fibroblasts, and that it may be a molecular link between arterial fibrosis and metabolic syndrome in rhesus monkeys. Using gene knockdown and overexpression approaches, the present study examined whether DDR2 is a target of metformin and whether, by targeting DDR2, it inhibits Fibronectin and Collagen type I expression in rat aortic adventitial fibroblasts exposed to hyperglycaemic conditions. Metformin was found to attenuate hyperglycaemia-induced increase in DDR2 mRNA and protein expression by inhibiting TGF-β1/SMAD2/3 signalling that mediates the stimulatory effect of hyperglycaemia on DDR2 expression. Metformin also inhibited DDR2-dependent expression of Fibronectin and Collagen type I, indicating that it regulates these matrix proteins via DDR2 inhibition. The findings identify DDR2, a mediator of cardiovascular remodelling, as a molecular target of metformin, thereby uncovering the molecular basis of its protective role in vascular fibrosis and possibly cardiac fibrosis associated with diabetic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Titus et al. (2022) studied Hyperglycemia-induced vascular fibrosis. Metformin vs. High glucose (30 mM) alone was evaluated on Fibronectin, Collagen type I, and DDR2 expression levels (p=≤0.05). Metformin significantly attenuated hyperglycemia-induced increases in DDR2, Fibronectin, and Collagen type I expression in vascular adventitial fibroblasts by inhibiting TGF-β1/SMAD2/3 signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: